Orthogonal Experiment for Optimization of the Sample Pretreatment Conditions for the Serum Cholesterol and Markers Determination by GC-MS

[1] Gylling H. International Journal of Clinical Practice, 2004, 58(9): 859.

[2] Mia Hedman, Miettinen Tatu A, Gylling Helena, et al. The Journal of Pediatrics, 2006, 148(2): 241.

[3] Miettinena Tatu A, Gylling Helena, Viikari Jorma, et al. Atherosclerosis, 2008, 200(1): 177.

[4] Silbernagel Guenther, Fauler Guenter, Renner Wilfried, et al. Journal of Lipid Research, 2009, 50(2): 334.

[5] Miettinen T A, Gylling H, Nissinen M J. Nutrition, Metabolism and Cardiovascular Diseases, 2011, 21(10): 765.

[6] Edwards Selvin H, Kimberly Mary M, Pyatt Susan D, et al. Clinical Chemistry, 2011, 57(4): 614.

[7] Zhou W, Li H, Dong J, et al. Clinical Chemistry and Laboratory Medicine, 2011, 49(4): 669.

[8] Hojo Kazuhiro, Hakamata Hideki, Takahashi A, et al. Journal of Chromatography B, 2011, 879(11-12): 751.

[9] Briche Céline S J Wolff, Carter David, Webb Kenneth S. Rapid Communications in Mass Spectrometry, 2002, 16(9): 848.

[12] Amaral C, Gallardo E, Rodrigues R, et al. Journal of Chromatography B, 2010, 878(23): 2130.